Coherus BioSciences, Inc(NASDAQ:CHRS) 
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline...
Website: http://www.coherus.com
Founded: 2010
Full Time Employees: 306
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.79
H 0.82
L 0.75
C 0.78
V 1,870,680
10EMA 0.78
20EMA 0.78
60EMA 0.78
120EMA 0.78
250EMA 0.78